Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:54 p.m.

    📋 Royalty Pharma plc (RPRX) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:36:00

    Event Type: Financial Results

    Event Details:

    Royalty Pharma (RPRX) Reports Q3 2022 Financial Results Royalty Pharma (RPRX) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: $536 million
    • Net Income: $16 million
    • EPS: Not disclosed
    • Cash and equivalents: $2
      • expected in the second half of 2022

    📊 Key Financial Metrics:

    Metric Value
    Revenue $536 million
    Net Income $16 million
    Cash $2

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Royalty Pharma
    • CIK: 0001802768
    • Ticker Symbol: RPRX
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories